Example: Heart Attack

Search clinical trials for: S768I

Total 6 results

NCT05267288

Recruiting

Phase II Study of Afatinib Plus Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon G719X, S768I, and L861Q Mutation Metastatic Non-Small Cell Lung Cancer

PFS
NCT07185997

Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Non-Small-Cell Lung Cancer | Metastatic Non-Small-Cell Lung Cancer | Advanced Non-Small-Cell Lung Cancer | EGFR P-Loop and Alpha C-Helix Compressing | EGFR PACC | EGFR Uncommon Mutations
NCT06706076

Recruiting

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations (SOLARA)

NSCLC (Advanced Non-small Cell Lung Cancer)
NCT06517953

Recruiting

Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations (IcomBine)

Non-small Cell Lung Cancer Metastatic | EGFR G719X | EGFR L861Q | EGFR S768I
NCT05548348

Recruiting

First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation

Non-small Cell Lung Cancer | EGFR G719X | EGFR L861Q | EGFR S768I

This is a preview
Log in or create a free account to see all matching trials and use the full search.
Log in | Register